Modafinil in the News

As Modafinil has been gaining more and more media attention, we have collected some of the top reports from the past few years and displayed them below. There are very positive statements to come out from people sharing their experience with Modalert and how it have helped them. Check them out below and click to read more.

[imageeffect image="1242" width="140" height="93" align="aligncenter" alt="BBC World News Modafinil Information"]

“Most of us want to reach our true potential. We might drink a cup of coffee to stay awake and alert, or go for a run, to feel on top of the job. So where’s the harm in a pill – a “smart drug” – that can do the same thing?”

– Susan Watts, BBC News

[imageeffect image="1241" width="160" height="73" align="aligncenter" alt="The Times News on Modafinil"]

A growing number of businessmen and women seeking an edge over colleagues and competitors are taking modafinil, a drug designed to treat narcolepsy, a disorder that causes people suddenly to fall asleep.
Read More >

– James Dean, The Times

[imageeffect image="1240" width="139" height="69" align="aligncenter" alt="Tech Crunch on Modafinil"]

What’s so funny is that entrepreneurs apparently aren’t interested in typical drugs – instead they find the one that gives them a mental and stamina advantage. Perhaps some enterprising venture capitalist will start requiring founders of their companies to get a prescription in order to close on an investment.
Read More >

– Michael Arrington, Tech Crunch

[imageeffect image="1239" width="160" height="95" align="aligncenter" alt="Intelligent Life Modafinil Works"]

At Cambridge over the summer, many students were taking pills to help their concentration. Ed Cumming was among them
Read More >

– Ed Cumming, Intelligent Life Magazine

[imageeffect image="1238" width="135" height="28" align="aligncenter" alt="Wired Magazine Modafinil Report"]

But modafinil isn’t just for soldiers and sick people anymore. This year, Cephalon submitted to the FDA a supplemental application that would give physicians a free hand to prescribe Provigil for lesser sleep problems, such as shift-work drowsiness. Even without that approval, the drug is attracting a wider market: Truckers, students, and others pulling all-nighters account for a growing portion of Provigil’s $200 million in annual sales.
Read More >

– Richard Martin,